Live tape
Top 8, mentions 7d29,700NVDA17,908 mentions▲ +0.03GOOGL2,107 mentions▲ +0.04MSFT2,056 mentions-0.02AMD1,808 mentions▲ +0.09SPCX1,731 mentions▲ +0.07AAPL1,616 mentions▲ +0.05NBIS1,263 mentions▲ +0.07SPY1,211 mentions▲ +0.05

Equity · Healthcare

TECH

NASDAQ

Bio-Techne (TECH)

72.30 USD +0.41% vs prior close
Bio-Techne Corporation price graph

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers.

Market cap
11.4B USD
P/E (TTM)
65.7
Revenue, year to Jun 2026
1.2B USD
EPS, diluted, year to Jun 2026
1.16 USD
52-week range
43.30 USD – 72.30 USD
Avg volume
1.1M

as of Aug 7, 2026

Have Bio-Techne (TECH) insiders bought or sold shares recently?

In the 90 days to 17 Nov 2026, no Bio-Techne insider bought or sold shares on the open market; all 15 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4).

Form 4, 90 days to 17 Nov 2026, newest Form 4 filing 1 Nov 2026

0buys
0sells
15other filings
Have Bio-Techne (TECH) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
01 Nov 2026Hippel JamesCFOOption exercise11,545
01 Nov 2026Hippel JamesCFOTax withheld5,096370K USD
01 Nov 2026Kelderman KimChief Executive OfficerTax withheld2,385173K USD
29 Oct 2026BAUMGARTNER ROBERT VDirectorAward2,750
29 Oct 2026Bushman Julie LDirectorAward2,750
29 Oct 2026HIGGINS JOHN LDirectorAward2,750
29 Oct 2026KEEGAN JOSEPH DDirectorAward2,750
29 Oct 2026Herr Amy E.DirectorAward2,750
29 Oct 2026Klimovsky Judith V.DirectorAward2,750
29 Oct 2026Seth AlpnaDirectorAward2,750
29 Oct 2026Vessey RupertDirectorAward2,750
28 Sep 2026HIGGINS JOHN LDirectorOption exercise15,940

Showing the 12 most recent of 15 compensation filings in this window. The figures above count all of them.

Which funds hold Bio-Techne (TECH)?

3 of the 45 institutional funds we track reported a Bio-Techne position for the quarter ended 30 Sep 2026 — a combined 32.6M USD; the latest of those filings landed 13 Nov 2026.

Form 13F

Which funds hold Bio-Techne (TECH)?
FundPositionSharesValueShares q/q
Marshall WaceAdded400,18429.0M USD+347.2%
GAMCO InvestorsAdded36,8502.7M USD+489.6%
Renaissance TechnologiesNew position12,900935K USD
Soros Fund ManagementExited

Have members of Congress traded Bio-Techne (TECH)?

The most recent congressional trade disclosed in Bio-Techne is a purchase by April McClain Delaney (house, MD), dated 05 Dec 2025.

STOCK Act disclosures

Have members of Congress traded Bio-Techne (TECH)?
TradedMemberTypeAmountFiled after
05 Dec 2025April McClain Delaneyhouse · Democrat–MDPurchase1K USD–15K USD31 days
22 Oct 2025April McClain Delaneyhouse · Democrat–MDPurchase1K USD–15K USD13 days
01 Aug 2025April McClain Delaneyhouse · Democrat–MDSale1K USD–15K USD32 days
26 May 2025April McClain Delaneyhouse · Democrat–MDSale1K USD–15K USD37 days
29 Apr 2025April McClain Delaneyhouse · Democrat–MDPurchase1K USD–15K USD3 days
09 Apr 2025April McClain Delaneyhouse · Democrat–MDPurchase1K USD–15K USD23 days
08 Apr 2025Robert P. Bresnahan, Jr.house · Republican–PASale1K USD–15K USD30 days
01 Apr 2025Julie Johnsonhouse · Democrat–TXSale1K USD–15K USD43 days

What has been filed or recorded for Bio-Techne (TECH)?

The filings we hold for Bio-Techne, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.

What has been filed or recorded for Bio-Techne (TECH)?
And
30 Sep 2026Quarterly earningsQ1 2027 reportedEPS 0.18 USDRevenue $300M
30 Sep 2026FinancialsTotal assets2.6B USDat period end
30 Sep 2026FinancialsTotal equity2.2B USDat period end
30 Jun 2026Annual reportFY 2026 reportedEPS 1.16 USDRevenue $1.22B
30 Jun 2026FinancialsRevenue1.2B USDfiscal year
30 Jun 2026FinancialsNet income to common shareholders181.8M USDfiscal year
30 Jun 2026FinancialsDiluted EPS1.16 USDfiscal year
31 Mar 2026Quarterly earningsQ3 2026 reportedEPS 0.32 USDRevenue $311M
31 Dec 2025Quarterly earningsQ2 2026 reportedEPS 0.24 USDRevenue $296M
30 Sep 2025Quarterly earningsQ1 2026 reportedEPS 0.24 USDRevenue $287M
30 Jun 2025Annual reportFY 2025 reportedEPS 0.46 USDRevenue $1.22B
31 Mar 2025Quarterly earningsQ3 2025 reportedEPS 0.14 USDRevenue $316M
31 Dec 2024Quarterly earningsQ2 2025 reportedEPS 0.22 USDRevenue $297M

What do people ask about Bio-Techne (TECH)?

From live data
What is Bio-Techne’s market cap?11.4B

Bio-Techne is worth 11.4B USD by market value as of 7 Aug 2026, which is the share price times the shares on issue from its SEC filings.

What is Bio-Techne’s P/E ratio?65.7

Bio-Techne has a price-to-earnings ratio of 65.7, as of 7 Aug 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.

What is Bio-Techne’s revenue?1.2B

Bio-Techne reported revenue of 1.2B USD for the year ended 30 Jun 2026, as filed with the SEC. See Filings

Have Bio-Techne insiders bought or sold shares recently?15 filings

In the 90 days to 17 Nov 2026, no Bio-Techne insider bought or sold shares on the open market; all 15 Form 4 filings in that window were grants, exercises, tax withholding or transfers (SEC Form 4). See Insiders

Which funds own Bio-Techne?3 of 45

3 of the 45 funds we track reported a Bio-Techne position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported positions were Marshall Wace, GAMCO Investors and Renaissance Technologies. See Funds

Have members of Congress traded Bio-Techne?9 trades

Yes. 9 trades in Bio-Techne appear in the congressional disclosures we hold; the latest is a purchase by April McClain Delaney (House, MD) dated 5 Dec 2025, filed 5 Jan 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

When did Bio-Techne last report earnings?0.18

Bio-Techne last reported earnings on 30 Sep 2026 for Q1 2027, with EPS of 0.18 USD; no next date is announced in SEC filings yet. See Filings

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. Wikimedia CommonsPortraits via Wikimedia Commons. Robert P. Bresnahan, Jr.: House Creative Services, Public domain; April McClain Delaney: Ike Hayman, House Creative Services, Public domain.
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
  8. SEC EDGARreported earnings figures and scheduled report dates
  9. SEC EDGARValuation computed from SEC EDGAR filings